Skip to Content

PARP inhibitors are showing promising results in treating ovarian cancer 

During the ESMO22 congress, BestPractice Nordic will meet one of the leading specialists in the treatment of Ovarian Cancer, Mansoor Raza Mirza. He will give his perspective on PARP inhibitors’ role in managing ovarian cancer.

Få tilgang til artikkelen

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top